2021 Annual Report cover

IBRI 2021 Annual Report “Accelerating Biomedical Innovation”

read the report

Li Lin

Research Associate

Joined the IBRI in September 2020

Li Lin

Li Lin works with Andrew Templin, PhD, on the mechanisms of diabetes pathogenesis related to islet immune responses and beta cell death. Her work includes management of in vivo studies to assess the metabolic and morphologic changes that occur in the animal models under investigation, and participation with in vitro studies examining novel beta cell death signaling pathways.

Before joining the Indiana Biosciences Research Institute, she worked as a research technician at University of Pittsburgh, where she was involved with lab operations and studies investigating antifungal immune response in the kidney and assisting Dr. Mattila with Mycobacterium Tuberculosis work.

View Lin's published research here.

Areas of Expertise

  • Agarose gel electrophoresis
  • Cell culture
  • DNA/RNA extraction
  • GraphPad Prism
  • Immunohistochemistry
  • Intraperitoneal injection
  • Intravenous injection
  • Polymerase chain reaction
  • Protein extraction
  • Western blot analysis

Education

  • Master of Public Health (Infectious Diseases and Microbiology), University of Pittsburgh, 2018
  • Bachelor of Science (Nursing), Wuhan University, 2016